This drug may reduce the risk of addiction to pain medications by decreasing reliance on opioids to reduce pain.

Many investors view the healthcare sector as a safe haven when the stock market is turbulent. Here are three no-brainer ...

Vertex Pharmaceuticals EVP Ourania Tatsis sold 3,242 shares worth $1.62 million under a pre-arranged plan. The sale, executed on March 10, 2025, priced each share at $499.99, with Tatsis still holding ...

Vertex Pharmaceuticals has dominated the cystic fibrosis (CF) market and is now expanding into new, high-growth areas. The ...

As of March 11, 2025, three stocks in the health care sector could be flashing a real warning to investors who value momentum ...

The Nasdaq Composite Index ( ^IXIC -4.00%) is now squarely in correction territory. But stock market corrections have one key ...

The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its ...

Incidents of children in the U.S. being poisoned by the synthetic opioid fentanyl “increased and became more severe”, a new ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.